A. Cheung

发表

Vaccine-elicited CD8+ T cells cure mesothelioma by overcoming tumor-induced immunosuppressive environment.

Zhiwei Chen, K. Yuen, K. Man, 2014, Cancer research.

Microenvironment and Immunology Vaccine-Elicited CD 8 þ T Cells Cure Mesothelioma by Overcoming Tumor-Induced Immunosuppressive Environment

Zhiwei Chen, K. Yuen, K. Man, 2014 .

Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells.

A. Cunningham, B. Slobedman, A. Abendroth, 2006, Blood.

Human cytomegalovirus latent infection and associated viral gene expression.

S. Avdic, B. Slobedman, A. Abendroth, 2010, Future microbiology.

The Activity-Induced Long Non-Coding RNA Meg3 Modulates AMPA Receptor Surface Expression in Primary Cortical Neurons

V. Anggono, J. Wong, Jocelyn Widagdo, 2017, Front. Cell. Neurosci..

PD1-based DNA vaccine amplifies HIV-1 GAG-specific CD8+ T cells in mice.

Zhiwei Chen, K. Yuen, Wenbo Yu, 2013, The Journal of clinical investigation.

PD 1-based DNA vaccine amplifies HIV-1 GAG-specific CD 8 + T cells in mice

Zhiwei Chen, K. Yuen, Wenbo Yu, 2013 .

Title PD 1-based DNA vaccine amplifies HIV-1 GAG-specific CD 8 + Tcells in mice

Zhiwei Chen, K. Yuen, Wenbo Yu, 2013 .

Viral Interleukin-10 Expressed by Human Cytomegalovirus during the Latent Phase of Infection Modulates Latently Infected Myeloid Cell Differentiation

S. Avdic, B. Slobedman, A. Abendroth, 2011, Journal of Virology.

The role of the human cytomegalovirus UL111A gene in down-regulating CD4+ T-cell recognition of latently infected cells: implications for virus elimination during latency.

B. Plachter, A. Cunningham, S. Avdic, 2009, Blood.

Microarrays for the study of viral gene expression during human cytomegalovirus latent infection.

B. Slobedman, A. Cheung, 2008, Methods in molecular medicine.

Potentiating functional antigen-specific CD8⁺ T cell immunity by a novel PD1 isoform-based fusion DNA vaccine.

Zhiwei Chen, Yanhua Du, Z. Tan, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

CCR5 Antagonist TD-0680 Uses a Novel Mechanism for Enhanced Potency against HIV-1 Entry, Cell-mediated Infection, and a Resistant Variant*

Zhiwei Chen, B. Zheng, Z. Tan, 2012, The Journal of Biological Chemistry.